09th week of 2009 patent applcation highlights part 38 |
Patent application number | Title | Published |
20090053279 | TISSUE REGENERATIVE COMPOSITION - A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. | 2009-02-26 |
20090053280 | COATING STENTS WITH CYCLIC RGD PEPTIDES OR MIMETICS - It is an object of the present invention to overcome certain disadvantages of stents, such as drug eluting stents. In particular, it is an object to provide a stent with improved re-endothelialization ability and/or simultaneous reduced rate of restenosis and/or minimal or no inflammatory potential. | 2009-02-26 |
20090053281 | EMBOLIZATION - Articles and methods that include a particle having a maximum dimension of at most 5,000 microns, and an embolic coil capable of binding to the particle, are disclosed. | 2009-02-26 |
20090053282 | Bone Grafting Method and Kit - Bone grafting methods involving harvesting at least of the following types of cells: osteoblasts, adult stem cells and primitive mesenchymal cells and applying these cells to a site intended for a bone graft in combination with the application of a suitable matrix material, where the matrix material is an allograft, xenograft or alloplast matrix material or a combination thereof. | 2009-02-26 |
20090053283 | Compositions And Methods For Treating Diseases - This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions. | 2009-02-26 |
20090053284 | MEDICAL DEVICES FOR USE IN THE SURGICAL TREATMENT OF HYPERPROLIFERATIVE DISEASES AFFECTING THE SPINAL CORD - Provided herein are new methods for the treatment of hyperproliferative diseases affecting the spinal cord, including the use of biodegradable polymers to treat spinal cord tumor recessing, i.e., to patch open zones left by spinal tumor removal. Biocompatible polymeric materials are tailored to fill areas previously occupied by tumors, e.g., materials in the form of tubular articles configured for insertion into the spinal column after surgical removal of a tumor. These protective articles may also include medicinal agents that stimulate spinal column neural regeneration, such as medicines or donor neuronal cells such as human neural stem cells, thus assisting patients to recover motorsensory function after spinal tumor surgery. | 2009-02-26 |
20090053285 | Medicament Carrier Composition and Method Of Forming A Film Therefrom - A medicament carrier composition includes a medicament and a polymer component including a polyvinylpyrrolidone having a weight average molecular weight of at least 700,000 g/mol. The medicament carrier composition has a viscosity of from 500 to 5,000 cps at 250 C, is substantially free of cellulose, and includes an auxiliary polymer. The medicament carrier composition is used to form a film that is also substantially free of cellulose. The film has a consistent thickness and size, and an increased flexibility and increased moisture resistance due to the polyvinylpyrrolidone. The medicament carrier composition is also used in a method of forming the film. The method includes the steps of providing the medicament and the polymer component. The method also includes the step of combining the polymer component and the medicament to form the medicament carrier composition. The method further includes the step of drying the medicament carrier composition to form the film. | 2009-02-26 |
20090053286 | PRODUCTS AND METHODS FOR MAINTAINING OR INCREASING CERAMIDE LEVELS IN SKIN - Disclosed are methods and products such as wet wipes and absorbents capable of providing a skin health benefit when utilized in the intended fashion. More specifically, the products described herein comprise an agent, such as a botanical extract, which is capable of increasing the activity of sphingomyelinase according to a Sphingomyelinase Activity Screening Test and/or decreasing the activity of ceramidase according to a Ceramidase Activity Screening Test. By increasing the activity of sphingomyelinase and/or decreasing the activity of ceramidase, the agents in combination with the products described herein are able to maintain or increase the level of ceramides in the skin leading to improved skin health. | 2009-02-26 |
20090053287 | POROUS DRESSING - A porous dressing is provided. The porous dressing includes a polymeric layer, a pharmaceutically active ingredient and a metal oxide. The polymeric layer has a porosity and a bio-compatibility, and the pharmaceutically active ingredient and the metal oxide distribute in one selected from a group consisting of in the polymeric layer, on a surface of the polymeric layer and a combination thereof. | 2009-02-26 |
20090053288 | Hemostatic woven fabric - The present invention is directed to a woven fabric having the modified crowsfoot weave pattern shown in FIGS. | 2009-02-26 |
20090053289 | KIT FOR THE TREATMENT OF A CORN OR CALLUS - The present invention is a kit for use by a person to apply a daily treatment of medication and therapy to remove a corn or callus from the person's skin while providing maximum comfort to the person and minimal damage to healthy skin. In one embodiment, the kit comprises a box, an AM treatment system, and a PM treatment system for application at night. The AM treatment system comprises a plurality of AM foam bandages each having a medicated foam pad of hydrocolloid. The PM treatment system comprises a plurality of PM foam protective covers and a plurality of PM medicated non-woven patches impregnated with salicylic acid. The PM treatment system allows the person to remove a single PM medicated patch, trim it to fit the shape of the corn, and position it as desired over the corn. The person may then remove a single PM foam protective cover and apply it over the PM medicated patch, covering it completely, thereby limiting migration of the salicylic acid to healthy skin. Upon removal of the PM foam protective cover, the PM medicated patch along with a portion of the dead skin is removed neat and clean. The treatment cycle begins anew, wherein the AM foam bandage has the opportunity to heal any healthy skin that my have inadvertently come into contact with the salicylic acid of the PM treatment system as well as softening additional dead skin of the corn prior to the application of the next PM treatment system. | 2009-02-26 |
20090053290 | TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN - Transdermal delivery compositions and topical compositions for application to the skin are provided. The transdermal delivery composition includes at least two penetrants working synergistically but by disparate biochemical pathways. In one embodiment, the transdermal delivery system includes benzyl alcohol and lecithin organogel. The transdermal delivery compositions are used in a variety of topical compositions as a means of transdermally delivering and topically administering different drugs and agents, including compositions promoting collagen biosynthesis, retinoids and skin lighteners, chemical denervation agents such as BOTOX®, anti-fungal agents, anesthetics and non-steroidal anti-inflammatory drugs (NSAIDs). In addition, these topical compositions may be used in combination with non-ablative treatment modalities, such as microdermabrasion, laser-based skin remodeling and radio-frequency-based skin remodeling. | 2009-02-26 |
20090053291 | FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS - The invention provides (a) an HIV Tat protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Nef protein or derivative thereof; or (b) an HIV Nef protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Tat protein or derivative thereof; or (c) an HIV Nef protein or derivative thereof linked to an HIV Tat protein or derivative thereof and a fusion partner. The invention further provides for a nucleic acid encoding such a protein and a host cell, such as | 2009-02-26 |
20090053292 | Moraxella catarrhalis protein, nucleic acid sequence and uses thereof - The invention discloses the | 2009-02-26 |
20090053293 | Nano Anticancer Micelles of Vinca Alkaloids Entrapped in Polyethylene Glycolylated Phospholipids - The present invention provides a nano-micellar preparation containing vinca alkaloids antitumor agent for intravenous injection, which cincludes a therapeutically effective amount of vinca alkaloids antitumor agent (vinblastine, vincristine, vindesine and vinorelbine), a phosphatide derivatized with polyethylene glycol, together with pharmaceutically acceptable adjuvants. The preparation is prepared by encapsulating the medicament with a nano-micelle to obtain the nano-micellar preparation containing vinca alkaloids antitumor agent for injection. The vinca alkaloids antitumor agent and the phosphatide derivatized with polyethylene glycol form a nano-micelle with a highly uniform particle size. In the micelle, the hydrophobic core of encapsulated medicament is surrounded by polyethylene glycol molecules to form a hydrophilic protective layer, so that the medicament is prevented from contacting with the enzymes and other protein molecules in blood and being recognized and phagocytozed by reticuloendothelial system in body, and the circulation time in vivo of the micelle is prolonged. | 2009-02-26 |
20090053294 | Anti Mineralocorticoid Therapy of Infection - Antimineralocorticoid compounds are disclosed for use in the prophylaxis and therapy of viral infections, especially the retroviral infection by HIV. These compounds can be administered alone or in combination with conventional anti-viral agents or anti-sense mineralocorticoid Steroid ReceptorNA or DNA mutants of heat shock proteins. | 2009-02-26 |
20090053295 | REGULATABLE FUSION PROMOTERS - Fusion promoters are described that combine a RNA polymerase III basal promoter and regulatory elements from RNA polymerase II regulatory regions, and which provide specific regulation of expression from the promoter. Such fusion promoters are useful, for example, for expressing RNAi agents in vivo. | 2009-02-26 |
20090053296 | METHODS AND COMPOSITIONS RELATING TO HPV-ASSOCIATED PRE-CANCEROUS AND CANCEROUS GROWTHS, INCLUDING CIN - The present invention concerns the use of E6 and/or E7 peptides from human papilloma virus (HPV) to evaluate a cell-mediated response in a patient infected with HPV to determine the prognosis for that patient with respect to the development or recurrence of pre-cancerous or cancerous growths, including cervical intraepithelial neoplasia (CIN). | 2009-02-26 |
20090053297 | COMPOSITIONS AND METHODS FOR LESS IMMUNOGENIC PROTEIN-LIPID COMPLEXES - The present invention provides compositions and methods for reducing the immunogenicity and increasing the circulating half-life of therapeutic proteins such as Factor VIII. The compositions comprise lipidic structures such as liposomes, micelles and cochleates comprising a negatively charged lipid and polyethylene glycol derivatized phosphatidyl ethanolamine. | 2009-02-26 |
20090053298 | COMPOSITIONS AND METHODS FOR INHIBITING CAR GENE EXPRESSION BY RNA INTERFERENCE - The present invention provides short interfering ribonucleic acid (siRNA), compositions and methods for inhibiting the CAR gene expression simply and rapidly, which can be used for evaluating toxicity of a chemical substance. | 2009-02-26 |
20090053299 | Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery - The present invention is in the fields of drug delivery, and specifically, cationic liposome-based vaccines. In embodiments, this invention provides methods of making ligand-targeted (e.g., antibody- or antibody fragment-targeted) liposomes useful for the delivery of molecules to induce immune responses against viral antigens or to treat or prevent viral diseases. The specificity of the delivery system is derived from the targeting ligands. | 2009-02-26 |
20090053300 | MONOCLONAL ANTIBODY, GENE ENCODING THE ANTIBODY, HYBRIDOMA, PHARMACEUTICAL COMPOSITION, AND DIAGNOSTIC REAGENT - Disclosed is a monoclonal antibody which has a heavy chain variable region containing amino acid sequences depicted in SEQ ID NOs:74, 76 and 78 and a light chain variable region containing amino acid sequences depicted in SEQ ID NOs:80, 82 and 84. The monoclonal antibody can be used as a cancer therapeutic agent which acts selectively on a cancer tissue of non-small lung cancer, pancreatic cancer, gastric cancer or the like. | 2009-02-26 |
20090053301 | SILICONE VESICLES CONTAINING ACTIVES - A process is disclosed for preparing a hydrophobic active loaded vesicle composition by admixing a hydrophobic active to a pre-formed silicone vesicle dispersion. The silicone vesicle compositions are useful in a variety of personal and healthcare compositions. | 2009-02-26 |
20090053302 | CANCER TREATMENTS - The present invention relates to liposome comprising encapsulated oxaliplatin and methods for making encapsulated oxaliplatin. The invention also relates to liposomes comprising oxaliplatin and another anticancer drug. The liposomes of the invention are useful in cancer treatments. | 2009-02-26 |
20090053303 | MEDICAL FOOD OR NUTRITIONAL SUPPLEMENT, METHOD OF MANUFACTURING SAME, AND METHOD OF MANAGING DIABETES - A medical food and/or nutritional supplement for oral administration by mammals includes α-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid. | 2009-02-26 |
20090053304 | Composition and method of producing a taste masking formulation of laxatives for bowel cleaning preparation prior to colonoscopy - This invention relates to a solid taste masking formulation of laxatives which can be dispersed in water for oral use for bowel cleaning preparation prior to colonoscopy procedures. This invention also relates to the methods to produce the taste masking laxative formulations. | 2009-02-26 |
20090053305 | Pharmaceutical Formulations - Improved pharmaceutical compositions are provided comprising one or more solubilized HIV protease inhibiting compounds having improved solubility properties in a medium and/or long chain fatty acid, or mixtures thereof, a pharmaceutically acceptable alcohol, and water. | 2009-02-26 |
20090053306 | Pharmaceutical Compositions of a 5-HT2A Serotonin Receptor Modulator Useful for the Treatment of Disorders Related Thereto - The present invention relates to certain pharmaceutical compositions of a 5-HT | 2009-02-26 |
20090053307 | IMMEDIATE-RELEASE THERAPEUTIC SYSTEMS FOR IMPROVED ORAL ABSORPTION OF 7-[(E)]-T-BUTY-LOXYMINOMETHYL] CAMPTOTHECIN - A pharmaceutical composition comprising a camptothecin as active ingredient is herein described. In particular immediate-release therapeutic systems are described for the improved oral absorption of | 2009-02-26 |
20090053308 | Release-Control Composition - The present invention relates to a controlled release capsule preparation for oral administration, which contains (i) a granule containing a physiologically active substance which is a compound represented by the formula: | 2009-02-26 |
20090053309 | ADHESIVE COMPOSITIONS FOR THE TREATMENT OF XEROSTOMIA - Compositions and methods for the treatment of xerostomia are disclosed herein. Methods for making the compositions are also disclosed herein. The compositions are designed for individuals having the physiologic ability to salivate but who do not salivate in sufficient quantity to satisfy their personal comfort level of oral hydration. The compositions are typically in the form of a film or tablet, preferably in the form of a sticker tablet, most preferably in the form of a double layer sticker tablet, where one layer contains a bioadhesive material and the second layer contains the sialogogic agent and the one or more lipids. The compositions adhere to a buccal surface or mucosal surface in the oral cavity for at least 15 minutes, preferably for at least 30 minutes. The compositions contain a therapeutically effective amount of one or more sialogogic agents and one or more lipids for treating xerostomia and a pharmaceutically acceptable bioadhesive carrier. The compositions optionally contain a non-lipid lubricant, a flavoring agent, and/or a buffering agent. The methods for treatment of xerostomia require placing the composition on the oral mucosa of a patient's mouth, preferably on the palate or the cheek. The composition will adhere to the mucosal surface and dissolve over a period of time. The composition is generally effective at treating or ameliorating the effects of xerostomia for a time period ranging from at least 30 minutes up to 8 hours following administration to the buccal or oral mucosa. | 2009-02-26 |
20090053310 | NOVEL SUSTAINED RELEASE DOSAGE FORM - The novel sustained release dosage form comprising an active agent and a combination of a non-swelling pH dependent release retardant and a non swelling pH independent release retardant polymer which provides pH-independent drug release for a considerable period of time after administration. | 2009-02-26 |
20090053311 | Pharmaceutical Compositions for Treating or Preventing Bone Conditions - Provided herein is a pharmaceutical composition for treating, preventing or ameliorating a bone or cartilage condition and methods of making and using the same. | 2009-02-26 |
20090053312 | Methodology and Composition for a Skin Lubricant - One possible embodiment of the invention could be a method of lubricating human skin comprising of the following steps, but not necessarily in the order shown: providing a composition of a gel formed from cross-linking siloxane polyethers, the gel being further micronized in one or more low viscosity, silicone fluids; applying an effective amount of the composition to a portion of the exterior surface of a skin; and moving the portion within at least a part of an elastic and flexible skin contact article. | 2009-02-26 |
20090053313 | Process for the preparation of a polymeric hydrogel based on a highly purified polyvinylalcohol and uses thereof - The present invention relates to the preparation of a completely biocompatible and injectable, crosslinked polymeric hydrogel based on a polyvinyl alcohol. Said polymer, which is produced in a highly purified form, proved particularly suitable for the preparation of a filler to be employed in medicine and cosmetics, for the purpose of filling, correcting or treating deficits of different kind, origin and size of the soft tissues. | 2009-02-26 |
20090053314 | SUBMICRONIZATION OF PROTEINS USING SUPERCRITICAL FLUIDS - An apparatus and a method for the submicronization of proteins using supercritical fluids is provided for feeding the supercritical fluid and feeding a protein solution using a precipitation vessel with a taper shape at its lower part, in which the precipitation vessel accommodates the supercritical fluid and the protein solution to generate submicroparticles of the protein, and a spray nozzle with coaxial arrangement having an outer nozzle for spraying the supercritical fluid and an inner nozzle for spraying the protein solution. | 2009-02-26 |
20090053315 | Thermo-Kinetic Mixing for Pharmaceutical Applications - Compositions and methods for making a pharmaceutical dosage form include making a pharmaceutical composition that includes one or more active pharmaceutical ingredients (API) with one or more pharmaceutically acceptable excipients by thermokinetic compounding into a composite. Compositions and methods of preprocessing a composite comprising one or more APIs with one or more excipients include thermokinetic compounding, comprising thermokinetic processing the APIs with the excipients into a composite, wherein the composite can be further processed by conventional methods known in the art, such as hot melt extrusion, melt granulation, compression molding, tablet compression, capsule filling, film-coating, or injection molding. | 2009-02-26 |
20090053316 | NANOCLUSTERS FOR DELIVERY OF THERAPEUTICS - The present invention discloses a nano-cluster that includes a plurality of nano-particles, wherein the nano-particles can disperse in response to an environmental cue. Also disclosed is a method of preventing, treating, or diagnosing a disease or condition in a subject comprising administering a therapeutically effective amount of a composition comprising nano-clusters of the present invention. | 2009-02-26 |
20090053317 | MICROPARTICULATE SYSTEMS FOR THE ORAL ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES - The present invention relates to gastroresistant and enterosoluble microparticulate systems for the encapsulation of biologically active substances selected from: flavonoids, vitamins, antioxidants, immunostimulants, starchy and non-starchy polysaccharides, probiotics, prebiotics, intestinal trophism regulators, oligoelements, enzymes and bioactive peptides. Such microparticulate systems allow the administration of the aforementioned nutraceutic substances to animals such as porcines, bovines, caprines, ovines, equids, canids, felines, camelids, lagomorphs, rodents, fowl, and other mammals, including humans, fish and crustaceans, increasing the bioavailability. | 2009-02-26 |
20090053318 | Forming Embolic Particles - Methods of making polymer particles, as well as related particles, compositions, and methods are disclosed. | 2009-02-26 |
20090053319 | Sore Throat Relief Composition And Method of Producing Same - The present invention provides a sore throat relief composition and a method of producing the composition comprising oleoresin | 2009-02-26 |
20090053320 | Disease and Pest Control Agent Containing Dissolved Microbubles Consisting of Oxygen and Ozone - The present invention relates to systems and methods for producing disease and pest control agent for plants and crops containing dissolved oxygen and ozone. This present invention of disease and pest control agent for plants and crops containing dissolved microbubbles of oxygen and ozone consists of 0.3-40 μm pore size microbubbles of ozone (03) 1.0-10.0 volume % and oxygen (O2) 99.0-90.0 volume % dissolved in water as colloids and the concentration of ozone in this solution is 1˜30 mg/l. This invention produces disease and pest control agent for plants and crops that contains microbubbles consisting of highly concentrated oxygen and ozone dissolved in water as colloid which is environmentally friendly and highly effective as pesticidal and germicidal agent. | 2009-02-26 |
20090053321 | Vaginal rinse with enhanced bacteriocidal activity - There are provided vaginal rinse compositions, consisting essentially of :a) 1-20 wt % of a mucosally acceptable peroxide, b) 0.5-15 wt % of a mucosally acceptable sulfate, bisulfate, pyrosulfate salt of an inorganic cation or mixtures thereof, and c) water to 100 wt %. There are further provided methods of preparing and using said compositions as well as kits for maintaining the components to prepare said compositions. | 2009-02-26 |
20090053322 | RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME - Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water. | 2009-02-26 |
20090053323 | Aqueous disinfectants and sterilants including transition metals - The present invention is drawn to disinfectant or sterilant compositions, which are human safe, e.g., food grade or food safe. In one embodiment, an aqueous disinfectant or sterilant composition can comprise an aqueous vehicle, including water, from 0.001 wt % to 50 wt % of a peracid, and from 0.001 wt % to 25 wt % of a peroxide. Additionally, from 0.001 ppm to 50,000 ppm by weight of a transition metal based on the aqueous vehicle content can also be present. The composition can be substantially free of aldehydes. Alternatively or additionally, the transition metal can be in the form of a colloidal transition metal. | 2009-02-26 |
20090053324 | Calcium supplements - A composition comprising at least 5%, by weight, of calcium and at least 5%, by weight, of magnesium wherein the composition is derived from marine algae. | 2009-02-26 |
20090053325 | Method of Controlling Floating Virus Infection - A method of controlling floating virus infection. The method includes the step of: supplying chlorine dioxide gas into a space where floating virus can be present by a gas concentration which allows the animal to live or stay, but deactivates the virus. | 2009-02-26 |
20090053326 | Compositions, Systems, and/or Methods Involving Chlorine Dioxide ("ClO2") - Certain exemplary embodiments can provide a composition of matter comprising chlorine dioxide dissolved in acetic acid. When stored, a concentration of the chlorine dioxide in the composition of matter can be retained, with respect to an initial concentration of chlorine dioxide in said composition of matter, at, for example, greater than 30% for at least 28 days. Certain exemplary embodiments can provide a method comprising releasing chlorine dioxide from a composition comprising chlorine dioxide dissolved in acetic acid. | 2009-02-26 |
20090053327 | CONCENTRATED AQUEOUS BROMINE SOLUTIONS AND THEIR PREPARATION - This invention provides concentrated aqueous biocidal solutions formed from bromine chloride, sodium hydroxide, and sulfamic acid. The weight ratio of bromine chloride:sodium hydroxide:sulfamic acid used in forming the concentrated solution is such that for every 10.5 to 11.5 parts by weight of bromine chloride used, 15.3 to 17.5 parts by weight of sodium hydroxide and 11.0 to 12.5 parts by weight of sulfamic acid are used, the biocidal solution containing at least about 100,000 ppm (wt/wt) of active bromine based on the total weight of the solution. | 2009-02-26 |
20090053328 | Nitric Oxide Enhancing Glutamic Acid Compounds, Compositions and Methods of Use - The invention provides novel compositions and kits comprising at least one nitric oxide enhancing glutamic acid compound, or a pharmaceutically acceptable salt thereof, and, optionally, at least one nitric oxide enhancing compound and/or at least one therapeutic agent. The invention also provides methods for (a) treating cardiovascular diseases; (b) treating renovascular diseases; (c) treating diabetes; (d) treating diseases resulting from oxidative stress; (e) treating endothelial dysfunctions; (f) treating diseases caused by endothelial dysfunctions; (g) treating cirrhosis; (h) treating pre-eclampsia; (j) treating osteoporosis; (k) treating nephropathy; (l) treating peripheral vascular diseases; (m) treating portal hypertension (n) treating diseases resulting from elevated levels of gamma-glutamyl transpeptidase and (O) the targeted delivery of compounds and nitric oxide to organs, cells or tissues containing the enzyme gamma-glutamyl transpeptidase. The nitric oxide enhancing glutamic acid compounds comprise at least one heterocyclic nitric oxide donor group and/or at least one nitroxide group. | 2009-02-26 |
20090053329 | COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS - Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown to induce a rapid onset of antipsychotic action and increase the number of responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic. | 2009-02-26 |
20090053330 | PROCESS FOR PREPARATION OF RHUS VERNICIFLUA EXTRACTS HAVING EXCELLENT ANTI-CANCER ACTIVITY AND ANTI-CANCER PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - Provided is a process for preparation of a | 2009-02-26 |
20090053331 | Hands and feet sanitizing system - A sanitizing system is provided which includes an antibacterial liquid composition formulated to sanitize and deodorize the hands, feet, and other areas of the body. The antibacterial liquid composition is adapted to be dispensed from a pump dispenser as a topical spray. | 2009-02-26 |
20090053332 | Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of | 2009-02-26 |
20090053333 | TREATMENT OF VEGETATION LIQUORS DERIVED FROM OIL-BEARING FRUIT - The present invention relates to processes for the treatment of liquors derived from oil-bearing fruit, for example from oil palm fruit, and to products therefrom. Typically a process involves removal of undissolved solids, oleaginous parts, colloids and higher weight molecules from the vegetation liquor to give an aqueous fraction containing phytochemicals, for example, flavonoids, phenolic acids and hydroxy acids. Subsequently, pH adjustment and solvent extraction upon said aqueous fraction realise an extract rich in hydroxy acids or phenolic acids or flavonoids or any combination thereof. Applications of the substances subject of this invention are to be found in drinks, edible products, tonics, health supplements, antioxidant additives, cosmetics, soaps, shampoos, detergents, drugs or medicinal products. | 2009-02-26 |
20090053334 | GHRELIN PRODUCTION PROMOTER - The objectives are to find a substance or a composition capable of promoting the production of ghrelin with physiological activities such as growth hormone secretion effect, and to provide a pharmaceutical comprising it as the active ingredient. The pharmaceutical is a ghrelin production promoter comprising Rikkunshi-to as the active ingredient. | 2009-02-26 |
20090053335 | HERBAL COMPOSITIONS FOR THE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) - The invention provides a herbal composition for the inhibition of HIV, comprising an organic extract of | 2009-02-26 |
20090053336 | Method and Formulations for Treating Candidiasis Using Morinda Citrifolia - The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed | 2009-02-26 |
20090053337 | COMPOSITION AND METHOD OF IMPROVING SKIN BARRIER FUNCTION OF COMPROMISED SKIN - A composition and method of improving skin barrier function of compromised skin by applying onto the compromised skin a composition containing: (a) a complex comprised of a metal-copper-antioxidant botanical pigment; (b) an extract of pinus pinaster bark; (c) an extract of pilewort; and (d) a carrier vehicle. | 2009-02-26 |
20090053338 | Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof - A method of extracting phytoprogestogenic compounds from herbs and their use in preparing a medicament for treating humans requiring progesterone replacement or supplement. Assay systems to quantify progesterone and progestogenic receptor activity and a method for assembling a kit for the assays are also provided. | 2009-02-26 |
20090053339 | COMPOSITION FOR TREATMENT OF MENOPAUSE - A method of using an herbal extract of the a mixture of: Herba Scutellaria barbata, Radix Sophora subprostratae, Radix Anemarrhena Semen Glycine sojae, Radix Glycyrrhiza, Rhizoma Rhei, Fructus Tritici levis, Radix Astragali, Radix Rehmania, Fructus Ligustri lucidi, Semen Zyziphi spinosa, | 2009-02-26 |
20090053340 | THERAPEUTIC USES OF TOMATO EXTRACTS - The invention provides the use of a water soluble tomato extract or an active fraction thereof for the manufacture of a medicament for lowering plasma triglyceride levels, the water soluble tomato extract or active fraction thereof being substantially free of lycopene and being substantially free from water-insoluble particulate material. | 2009-02-26 |
20090053341 | Preventative and Treatment Effects of Morinda Citrifolia as an Aromatase Inhibitor - The present invention is directed to methods of inhibiting Aromatase or Aromatase enzymes that function to convert androgens to estrogens, inhibiting receptors from binding with estrogen, and reducing and/or regulating estrogen production, as well as reducing the amount of estrogen produced within the body and regulating such production. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed | 2009-02-26 |
20090053342 | PREPARATION OF MICROBIAL OIL - The present invention provides a process for the production of a microbial oil comprising culturing a micro-organism in a two stage fermentation process where, in a last stage that precedes the end of fermentation, the carbon source is: consumed by the micro-organisms at a rate greater than it is added to the medium; added at a rate #0.30 M carbon/kg medium; or is rate limiting on the growth of the micro-organism. The micro-organisms thus have the carbon source restricted so that they preferentially metabolise fats or lipids other than arachidonic acid (ARA), so increasing the proportion of ARA in the cells. A microbial oil is then recovered from the micro-organism, using hexane as a solvent, that has at least 50% ARA and at least 90% triglycerides. | 2009-02-26 |
20090053343 | Kits and Methods for Assessing Leptin-Mediated Lipid Metabolism - The invention relates to kits and methods for assessing susceptibility of a human to abnormal lipid metabolism and disorders associated therewith, such as obesity and diabetes. The methods involve assessing occurrence in the human's genome of one or more polymorphisms (e.g., single nucleotide polymorphisms) that occur in one or more genes associated with leptin-mediated lipid metabolism and that are associated with a disorder in humans. Preferred assessment and scoring methods are disclosed, as are kits for performing the methods. | 2009-02-26 |
20090053344 | METHOD FOR CURING TIRES AND A SELF-LOCKING TIRE MOLD - A segmented mold | 2009-02-26 |
20090053345 | Concrete slip forming device - The present invention is an improved slip forming device for forming a concrete curb having a desired profile. The device consists of a hopper portion and a removeable extruder portion, the extruder portion being adapted and configured to extrude the concrete curb having the desired profile. The hopper portion of the invention has a top, an open bottom, side walls and a back wall having an opening. The extruder portion of the invention has a front wall, a back wall, a closed top, and open bottom and side walls. The front wall of the extruder has a front opening and the back wall of the extruder has a rear opening, the top and side walls of the extruder forming a channel between the front and rear openings of the extruder. The rear opening of the extruder is substantially in the form of the desired profile. The front wall of the extruder is releasably mounted to the back wall of the hopper such that the front opening of the extruder is in communication with the opening of the hopper. The device includes a pair of mounting arms mounted to the hopper and extending away from the hopper, the extruder being mounted to the support arms. The extruder is releasably mounted to the hopper by means of a plurality of mounting flanges positioned on the back wall of the hopper and the front wall of the extruder, the mounting flanges being held together by mounting bolts. | 2009-02-26 |
20090053346 | PREVENTING MOLD USE BY DISABLING MOLDING CYCLE COMPONENTS - Presented herein is a system for preventing the unauthorized use of a mold, said system comprising a mold comprising at least two cooperating mold sections that are required by a mold cycle; and a lock assembly operatively associated with said mold; wherein, when the mold is mounted on a molding machine and the lock assembly is in the locked position, the system allows disabling at least one of the components required to complete a mold cycle. According to some embodiments, the lock assembly may further comprise an electronic control that may be accessed remotely or locally or both. According to some embodiments, the system may further comprise a counter operatively associated with the lock assembly. | 2009-02-26 |
20090053347 | MOLDING MACHINE SYSTEM - Provided is a molding machine system enabling a free setting of execution timings of respective steps in a molding cycle of heating of a mold, injection and pressure holding of a molding material, cooling of the mold, etc. The molding machine system repeating a series of molding cycle comprises three temperature sensors arranged at predetermined places of a mold, a change-over valve unit having a heat medium channel by which heating medium from a heating unit, cooling medium from a cooling unit and pressurized air are changed over to be supplied into and recovered from the mold and a molding control means, provided on the change-over valve unit, having a temperature judging program judging respective detected temperatures of the three temperature sensors to give a judgement result and a timer to give a time set signal. A molding operation control is carried out by combining the judgement result with the time set signal and enables an arbitrary supply control of the heating medium, cooling medium and pressurized air to be supplied into the mold and an arbitrary supply control of the molding material to be supplied into the mold. | 2009-02-26 |
20090053348 | Injection Apparatus - In an injection apparatus of a molding machine, a bad influence given to a molded product due to a water component contained in a resin is eliminated by maintaining the resin immediately before being melted in a dry state. The injection apparatus has a cylinder ( | 2009-02-26 |
20090053349 | INJECTION MOLDING MACHINE HAVING FUNCTION FOR MONITORING SCREW ROTATING TORQUES - Screw rotation speeds and screw rotating torques are measured at predetermined time intervals during metering and substituted into a previously-assumed function to determine a maximum screw rotating torque at each screw rotation speed. An allowable upper limit of screw rotating torque is set for each screw rotation speed on the basis of the determined maximum screw rotating torque. If a screw rotating torque exceeding the allowable upper limit is detected during metering after the allowable upper limit is set, the screw rotation is stopped or changed. | 2009-02-26 |
20090053350 | Pressure compensating molding system - A pressure compensating molding system with die faces of thin sheets. A thin die sheet separates a mold cavity from a heating/cooling cavity. A heating system causes a heated fluid to flow through the heating/cooling cavity, thereby preheating the thin sheet. The injection material is forced through a sprue into the mold cavity. Pressure sensors monitor the pressure of the injection material in the mold cavity and in the heating/cooling cavity. A controller varies the pressure in the heating/cooling cavity to equalize a pressure differential across the thin die sheet. A cooling system causes a cooling fluid to flow through the heating/cooling cavity to cool the molded component. | 2009-02-26 |
20090053351 | APPARATUS FOR FORMATION OF AN OPHTHALMIC LENS PRECURSOR AND LENS - This invention discloses apparatus for generating an ophthalmic lens with at least a portion of one surface free-formed from a Reactive Mixture. In some embodiments, an ophthalmic lens is formed on a substrate with an arcuate optical quality surface via a source of actinic radiation controllable to cure a definable portion of a volume of Reactive Mixture. | 2009-02-26 |
20090053352 | TAPER FITTED CONDUITS FOR MOLTEN POLYMER - A system for conveying fluids, particularly molten polymer in an extrusion melt train. The system has a first element having a first fluid passage. The first element also has a first interface surface thereon, such that the first interface surface is non-orthogonal to the axis of the first fluid passage. The first element also has a first interlocking feature. The system also has a second element having a second fluid passage. The second element also has a second interface surface thereon, such that the second interface surface is non-orthogonal to the axis of the second fluid passage. The second element also has a second interlocking feature. In use, the first element and the second element are placed in a linking position adjacent each other such that the first fluid passage is in fluid communication with the second fluid passage. | 2009-02-26 |
20090053353 | DEVICE FOR FORMING OPTICAL LENSES - A device for forming optical lenses includes a base, a driving mechanism mounted on the base, a controller connected to the driving mechanism and a roll forming die. The controller is configured for controlling the driving mechanism. The roll forming die includes a roller, a number of mold cores attached to the roller, and a molding material container disposed on the base and spaced with the roller. The roller is mechanically coupled to the driving mechanism such that the roller can be driven to rotate by the driving mechanism, the roller, the mold cores and the molding material container are arranged to cooperatively form workpieces. A number of mounting holes are defined in the roller; each of the mold cores is mounted in a corresponding mounting hole. The device for forming optical lenses can reduce internal stress of produced optical lenses. | 2009-02-26 |
20090053354 | VENTING VALVE TO BE USED IN VENTING BORES OF VULCANIZATION MOLDS - Vent valve for venting bores of vulcanization moulds, especially for the tread profile area, consisting of a valve sleeve ( | 2009-02-26 |
20090053355 | Gas extraction method from mold cavity - A gas extraction method including: providing an injection mold apparatus ( | 2009-02-26 |
20090053356 | Mineral Additive for a Dietary Composition for Animals and Method for the Production Thereof - The invention relates to an additive mineral for a dietary composition for animals comprising, in a biodigestible form, at least one phosphoric acid salt and a compound capable of forming a salt therewith. The additive is in the form of an aqueous solution in which the salt is in a dissolved state and is provided in the form of phosphate ions and of ions of said compound. The invention also relates to a method for producing the additive and to a device for carrying out this method. | 2009-02-26 |
20090053357 | Corn-based feed product - This application is directed to a corn-based feed component formed from a combination of corn components. The feed components described herein generally include at least about 75 percent by weight of a combination of corn components. Generally, the corn components of the feed products are low in starch as compared to whole kernel corn, and are thus somewhat enriched in bran and germ (as determined, for example, on a dry mass basis). Typically, such feed components have a glycemic response comparable to that of rolled oats, thereby providing a source of energy that is safer than corn, and equally as safe as oats and high fat rice bran. | 2009-02-26 |
20090053358 | Sulfate Ion Transporter Gene and Use Thereof - The present invention relates to a brewery yeast having enhanced sulfite-producing capability, a process for producing alcoholic beverages with enhanced sulfite amount. More particularly, the present invention relates to a yeast whose sulfite-producing capability that contribute to the product flavor is enhanced by increasing the expression level of SUL2 gene encoding brewery yeast sulfate ion transporter Sul2p, particularly non-ScSUL2 gene specific to lager brewing yeast, and to a method for producing alcoholic beverages with said yeast. | 2009-02-26 |
20090053359 | AMMONIA TRANSPORTER GENE AND USE THEREOF - The present invention relates to ammonia transporter genes and use thereof. The invention relates in particular to a brewer's yeast which shows enhanced ammonia assimilation, alcoholic beverages produced using such yeast, and a method of producing such alcoholic beverages. More specifically, the invention relates to the MEP3 gene which codes for the ammonia transporter Mep3 in brewer's yeast, particularly to a yeast which can control the ammonia assimilation ability by controlling the level of expression of the nonScMEP3 gene or ScMEP3 gene characteristic to beer yeast and to a method of producing alcoholic beverages using such yeast. | 2009-02-26 |
20090053360 | GENE ENCODING GLYCOGEN SYNTHASE AND USE THEREOF - The present invention relates to a gene encoding glycogen synthase and use thereof, in particular, a yeast for practical use with superior resistance property to dryness and/or low-temperature storage, alcoholic beverages produced with said yeast, and a method for producing said beverages. More particularly, the present invention relates to a yeast, whose resistance property to dryness and/or resistance property to low-temperature storage is enhanced by amplifying expression level of GSY1 or GSY2 gene encoding a Gsy1p or Gsy2p which is a glycogen synthase in brewer's yeast, especially non-ScGSY1 gene or non-ScGSY2 gene specific to a lager brewing yeast and to a method for producing alcoholic beverages with said yeast, etc. | 2009-02-26 |
20090053361 | OLIVE POMACE VINEGAR - The present invention discloses olive pomace vinegar, wherein the pomace is obtained during the olive oil processing. The invention also discloses a method for producing olive pomace vinegar comprising admixing olive pomace, water, carbohydrate source and fermenting microorganisms. | 2009-02-26 |
20090053362 | NOVEL UPASES AND USES THEREOF - The present invention to newly identified polynucleotide sequences comprising genes that encode novel lipolytic enzymes LIP01-LIP03. The LIP01 enzyme may be isolated from | 2009-02-26 |
20090053363 | Method for Producing Soybean Paste Containing Pine Mushroom - The present invention relates to a method for producing a soybean paste containing pine mushrooms, which comprises processing pine mushrooms, mixing the processed pine mushrooms with fermented soybeans (meju), fermenting and maturating the meju mixed with the processed pine mushrooms, wherein the step of processing pine mushrooms comprises shattering raw pine mushrooms which are neither heated nor dried; boiling grains in water, maturating the boiled grains, drying the mature grains and pulverizing the dried grains to grain powder; and mixing the shattered pine mushrooms with the resulting grain powder, kneading the resulting mixture and drying the resulting dough. According to the present invention, we can produce a soybean paste containing pine mushrooms, which can maximize the unique tastes, flavors and nutritive elements of pine mushrooms and minimize the loss of nutritive elements in soybeans. | 2009-02-26 |
20090053364 | LOW-INGREDIENT MEAT PRODUCTS AND METHOD FOR THEIR PREPARATION - Low-ingredient meat products, which contain a reduced amount of salt, phosphate and/or meat, generally have poor texture and water-binding properties. The texture and water binding of such a product may be significantly improved with tyrosinase, which is a protein cross-linking enzyme. The invention is directed to a method of preparing a low-ingredient meat product by adding tyrosinase, and to a low-ingredient meat product modified by tyrosinase. | 2009-02-26 |
20090053365 | Refreshment system having peel away nutrient and supplement packages - A liquid containing vessel is provided with one or more peel away packages housing nutritional and supplement ingredients. The packages are made from sealed polyethylene film having a continuous aluminum coating, which is moisture resistant and enables the packages to withstand washing of the vessel. Each of the packages has a notch therein to facilitate tearing. One or more packages are torn open, and the ingredients contained therein are emptied into the bottled water to create a custom beverage. The nutritional ingredients can include a vitamin and/or mineral composition or an electrolyte composition. The supplement composition can include a flavor enhancer, a taste enhancer or a medically effective agent. | 2009-02-26 |
20090053366 | Refreshment system having effervescent supplement tablets - An effervescent supplement tablet is especially adapted for use in a beverage. The tablet contains a supplement ingredient and effervescent ingredients, including citric acid and sodium bicarbonate. The effervescent supplement tablet may additionally contain nutritional ingredients, such as vitamins or/and minerals, flavoring, sugars, sweeteners and/or medicaments, minerals or an electrolyte. Such effervescent supplement tablets are housed in one or more peel away packages that are adhesively attached to an external surface of a water-containing vessel, so that the effervescent supplement tablets are part of a fluid refreshment system. The packages are made from sealed polyethylene film having a continuous aluminum coating, which is moisture resistant and enables the packages to withstand washing of the vessel. Each of the packages has a notch therein to facilitate tearing. One or more packages are torn open, and the effervescent supplement tablet is emptied into the bottled water to create a custom beverage. Refill packages containing peel away effervescent supplement tablet packages can be marketed separately from the fluid refreshment system/kit, thereby enabling the effervescent supplement tablets to be purchased separately. | 2009-02-26 |
20090053367 | Kinetic Beverage for Delivery of Physiologically Active Substances - The invention pertains to a delivery system for delivery of at least one physiologically active ingredient in a pleasant and palatable manner. One preferred embodiment is a beverage mix comprising a plurality of morsels, each morsel comprising a core, a plurality of effervescent zones, at least one barrier zones, wherein the at least one barrier zone temporarily protects the plurality of effervescent zones. When a beverage is immersed in water, the barrier zone prevents water reaching the effervescent zone. The at least one barrier zone deteriorates exposing the effervescent zones in sequence. The effervescent zones dissolve and carbon dioxide gas is released. Gas bubbles coat the morsel and it rises. When the gas bubbles disengage from the morsel, the morsel falls. The process repeats until all of the effervescent zones are exposed. The drink comprising gelatinous cores in carbonated water is ready for consumption. | 2009-02-26 |
20090053368 | CORN PROTEIN CONCENTRATES - The invention provides for corn protein concentrates (CPC). The CPC described herein can be used in food products for consumption by humans. | 2009-02-26 |
20090053369 | JELLY CANDY - A jelly candy is disclosed, which is capable of preventing an obstruction of an airway of a human body when eating the jelly candy, with a vertical through hole being formed at a center in an axial direction of a jelly. | 2009-02-26 |
20090053370 | Package for molded food product and method - A solid food product is molded in a mold cavity and is thereafter packaged in the mold cavity. The mold cavity is formed in a sheet and includes a side wall which extends from the sheet and a bottom wall which includes an inverting portion which extends from said side wall and a central portion. The central potion of the bottom wall includes a plurality of ridges which form a decorative design. A liquid food product is introduced into the mold cavity and allowed to solidify to form a molded solid food product. The central portion of the bottom wall is thereafter pushed into the mold cavity to invert said inverting potion and to push the molded food product away from the central portion of the bottom wall. The molded food product includes ridges which correspond to the ridges in the bottom wall of the mold cavity. A lid is attached to the sheet to enclose and package the molded food product within the mold cavity. | 2009-02-26 |
20090053371 | Package for storing, shipping, preparing and dispensing a meal - The present invention relates to a novel package for storing, shipping, preparing and dispensing a meal. In one embodiment the present invention provides for a meal comprising an array of shellfish and vegetables disposed in a tray, which is disposed in a flavor pouch. The package has sufficient structural integrity to withstand shipping and when purchased by the customer, is ready to bake or grill. When prepared by the customer a substantial array of perfectly prepared seafood, steamed in a seasoned butter sauce, is presented. The visual presentation, ease of preparation, uniqueness of combination and high quality ingredients makes a wonderful meal for two or more. | 2009-02-26 |
20090053372 | RESEALABLE FOOD BAGS AND METHOD THEREOF - Embodiments of the present invention generally relate to resealable food bags utilizing an adhesive compound, and a method thereof. In one embodiment of the present invention, a resealable food stuff bag comprises a food stuff bag with an interior and an exterior, and an adhesive tape applied to the interior of the food bag, wherein the adhesive tape comprises a carrier with a first side and a second side, a layer of food-grade permanent adhesive applied to the first side of the carrier, and a layer of food-grade removable adhesive applied to the second side of the carrier. | 2009-02-26 |
20090053373 | Processes for treating roasted coffee beans with steam - The present invention aims to provide a steam treatment process for stably preparing steam-treated roasted coffee beans having constant flavor quality by reducing variation in the degree of roasting between different sites in the system during steam treatment of roasted coffee beans without complicating operation processes or increasing costs. | 2009-02-26 |
20090053374 | Beverage Container - A beverage container including a base defining a primary volume for holding the beverage. A neck having an open top extends from the base and defines a passageway in fluid communication with the primary volume and the open top. A secondary volume defined by the neck intersects the passageway for holding a beverage flavoring disposed in the passageway for flavoring the beverage flowing from the primary volume through the passageway. | 2009-02-26 |
20090053375 | System and method for making blended frozen products with liquid nitrogen - A system and method for making frozen, blended confections utilize liquid nitrogen to partially freeze the confection. A liquid or slurry is first placed in a blender and during blending, liquid nitrogen is introduced at a controlled rate so that the liquid partially freezes and the liquid nitrogen is exhausted out the top of the blender in a visually exciting manner. The blending action and the delivery of liquid nitrogen is synchronized by a computer-controlled algorithm to ensure consistent results. | 2009-02-26 |
20090053376 | Process and Device for Casting Products Intended for Human Consumption - The invention relates to a casting machine for producing a product intended for human consumption from a castable material, in particular a fat material such as chocolate, for example, having a heatable material container for receiving the castable material; at least one nozzle which is in fluid connection with the material container interior, and a pressure source for generating an overpressure in the material container interior. According to the invention, the nozzle has a nozzle orifice or a nozzle constriction, the open cross section or flow cross section of which is flexible. A process according to the invention for producing a product intended for human consumption from a castable material has the following steps: providing a heated castable material in a material container; generating an overpressure in the material container interior, forcing the material through a nozzle in fluid connection with the material container with simultaneous changing of the flow and/or open cross section of the nozzle. | 2009-02-26 |
20090053377 | PROPORTIONAL LENGTH FOOD SLICING SYSTEM - This invention includes a system for cutting food products, such as potatoes, into proportional length pieces. In a one embodiment, the system includes a cutting assembly, sensors upstream of the cutting assembly and a programmable logic controller. The cutting assembly preferably includes a housing defining a passageway, at least two separately actuatable stops extendable into the passageway to provide an abutment to hold the food product in place, and at least two separately actuatable blades for slicing the food product into pieces. The controller cooperates with the sensors to determine the length of each food product and, based on a length determinative algorithm, selectively actuate one of the stops and at least one of the blades to determine how many times the food product will be sliced and location of the cut(s) relative to the leading end of the food product. | 2009-02-26 |
20090053378 | Sweetener Compositions Having Enhanced Sweetness and Improved Temporal and/or Flavor Profiles - The present invention relates generally to improving the taste of sweetener compositions having enhanced sweetness. In particular, the present invention relates to compositions that can improve the tastes of sweetness enhanced sweetener compositions including at least one sweetness enhancer and at least one sweetener by imparting a more sugar-like taste or characteristic. In particular, the compositions and methods provide at least one sweetness enhancer, at least one sweetener comprising a carbohydrate sweetener, a natural-high-potency sweetener, a synthetic high-potency sweetener, or a combination thereof, and at least one sweet taste improving composition. | 2009-02-26 |